OnChip Prep & PSR Series
-
The technology to analyze the specific single-strained
Aptamer bounded biological molecules -
Can process examination with a few amounts of blood
-
Few restriction on subjects
-
Lower risk compares to the radiation exposure from CT examination and side effects of the tissue biopsy
-
Utilize the artificial intelligence(AI) technology contained software, AptaDx™
CaresLinx Pro Series
CareLink의 차세대 신장질환 치료제
"신장질환 치료의 패러다임을 바꾸는 새로운 가능성."
CareLink의 치료제는 기존 신장질환 치료제의 한계를 극복하고, 근본적인 치료가 가능하도록 개발되고 있습니다.
Original Technology
원천 기술 소개
-
We specialise in the design, development and production of probe cards.
-
We are the second largest manufacturer of probe cards in the world in terms of volume and turnover.
Clinical Trial Results
Definition
-
Derived from Latin word “aptus” which means “perfectly suited”
-
Oligonucleotides (20~60 nucleotides, DNA or RNA)
-
Targeted molecules varies. It is from small particles to proteins.
-
High Affinity(affinity, Kd= nM~pM) and Specificity(Kd/Kd'=~10-5)
-
Affinity is 1000 times higher than antibodies and antigens, leading to recognition as a new drug candidate.
관련 특허
Description
-
Derived from Latin word “aptus” which means “perfectly suited”
-
Oligonucleotides (20~60 nucleotides, DNA or RNA)
-
Targeted molecules varies. It is from small particles to proteins.
-
High Affinity(affinity, Kd= nM~pM) and Specificity(Kd/Kd'=~10-5)
-
Affinity is 1000 times higher than antibodies and antigens, leading to recognition as a new drug candidate.